microRNA information: hsa-miR-146a-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-146a-5p | miRbase |
Accession: | MIMAT0000449 | miRbase |
Precursor name: | hsa-mir-146a | miRbase |
Precursor accession: | MI0000477 | miRbase |
Symbol: | MIR146A | HGNC |
RefSeq ID: | NR_029701 | GenBank |
Sequence: | UGAGAACUGAAUUCCAUGGGUU |
Reported expression in cancers: hsa-miR-146a-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-146a-5p | B cell lymphoma | deregulation | "MicroRNA 146a rs2910164 polymorphism and the risk ......" | 25370733 | qPCR |
hsa-miR-146a-5p | bladder cancer | upregulation | "We found that miR-146a rs2910164 C allele was asso ......" | 22846912 | |
hsa-miR-146a-5p | breast cancer | downregulation | "We also show that low expression of miR-146a stron ......" | 25417703 | |
hsa-miR-146a-5p | breast cancer | downregulation | "Associations of miR 146a and miR 146b expression a ......" | 26406414 | |
hsa-miR-146a-5p | cervical and endocervical cancer | upregulation | "Increased exosomal microRNA 21 and microRNA 146a l ......" | 24406730 | qPCR |
hsa-miR-146a-5p | cervical and endocervical cancer | upregulation | "The occurrence of cervical cancer in Uygur women i ......" | 26464690 | qPCR |
hsa-miR-146a-5p | colon cancer | downregulation | "To present proof-of-principle application for empl ......" | 23741026 | qPCR; Microarray |
hsa-miR-146a-5p | colon cancer | downregulation | "Expression of miR 146a in colon cancer and its sig ......" | 24670457 | qPCR |
hsa-miR-146a-5p | colorectal cancer | downregulation | "Association of a genetic variant in microRNA 146a ......" | 24740563 | |
hsa-miR-146a-5p | gastric cancer | downregulation | "MicroRNA 146a is down regulated in gastric cancer ......" | 21347720 | qPCR |
hsa-miR-146a-5p | gastric cancer | deregulation | "miRNA expression signature was first analyzed by r ......" | 21628394 | qPCR |
hsa-miR-146a-5p | gastric cancer | upregulation | "Our previous studies have revealed that miR-146a i ......" | 22020746 | qPCR |
hsa-miR-146a-5p | gastric cancer | upregulation | "The real-time PCR was used to evaluate the effect ......" | 23706078 | qPCR |
hsa-miR-146a-5p | gastric cancer | downregulation | "The clinical significance of downregulation of mir ......" | 24805774 | Microarray |
hsa-miR-146a-5p | head and neck cancer | downregulation | "Characterization of miR 146a and miR 155 in blood ......" | 26621153 | qPCR; Microarray |
hsa-miR-146a-5p | kidney renal cell cancer | downregulation | "Effect of a functional polymorphism in the pre miR ......" | 26323945 | |
hsa-miR-146a-5p | liver cancer | downregulation | "Expression and clinicopathological significance of ......" | 24172202 | qPCR |
hsa-miR-146a-5p | liver cancer | downregulation | "Previously we found that the expression of microRN ......" | 24895573 | |
hsa-miR-146a-5p | liver cancer | downregulation | "Growing evidence indicates that miR-146a is involv ......" | 25608619 | |
hsa-miR-146a-5p | lung squamous cell cancer | downregulation | "Aberrant expression of microRNA-146a miR-146a has ......" | 23555954 | |
hsa-miR-146a-5p | lung squamous cell cancer | upregulation | "microRNA 146 up regulation predicts the prognosis ......" | 24448024 | in situ hybridization |
hsa-miR-146a-5p | lung squamous cell cancer | deregulation | "In this study we evaluated the expression profiles ......" | 27533249 | |
hsa-miR-146a-5p | lymphoma | downregulation | "Clinical and epidemiological data suggest that chr ......" | 22307176 | Reverse transcription PCR; in situ hybridization |
hsa-miR-146a-5p | melanoma | upregulation | "Moreover as expected some discrepancies were also ......" | 20442294 | qPCR; Microarray |
hsa-miR-146a-5p | melanoma | upregulation | "Interestingly miR-146a was upregulated in the seru ......" | 25951497 | |
hsa-miR-146a-5p | ovarian cancer | upregulation | "We analyzed the miRNA expression profiles of prima ......" | 23554878 | qPCR |
hsa-miR-146a-5p | pancreatic cancer | downregulation | "Eighty-eight samples of ductal pancreatic adenocar ......" | 22850622 | qPCR |
hsa-miR-146a-5p | pancreatic cancer | downregulation | "Expression analysis of miR-146a in human PC tissue ......" | 24839931 | |
hsa-miR-146a-5p | sarcoma | downregulation | "Similar analysis in mouse metastatic sarcomas reve ......" | 26044957 | |
hsa-miR-146a-5p | thyroid cancer | upregulation | "Associations of miR 146a and miR 146b expression a ......" | 25524940 | |
hsa-miR-146a-5p | thyroid cancer | upregulation | "Family of microRNA 146 Regulates RARβ in Papillar ......" | 27011326 |
Reported cancer pathway affected by hsa-miR-146a-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-146a-5p | breast cancer | Apoptosis pathway | "Overexpression of miR 146a in basal like breast ca ......" | 25123132 | RNAi |
hsa-miR-146a-5p | breast cancer | Apoptosis pathway | "Quercetin inhibits proliferation and invasion acts ......" | 25596948 | |
hsa-miR-146a-5p | breast cancer | Apoptosis pathway | "Catalpol suppresses proliferation and facilitates ......" | 26458573 | Flow cytometry; MTT assay |
hsa-miR-146a-5p | colon cancer | cell cycle pathway; Apoptosis pathway | "Expression of miR 146a in colon cancer and its sig ......" | 24670457 | Flow cytometry |
hsa-miR-146a-5p | colorectal cancer | Wnt signaling pathway | "Target resequencing to identify microRNA associate ......" | 26813595 | |
hsa-miR-146a-5p | gastric cancer | Apoptosis pathway; cell cycle pathway | "MicroRNA 146a is down regulated in gastric cancer ......" | 21347720 | MTT assay |
hsa-miR-146a-5p | gastric cancer | Apoptosis pathway | "Increased miR 146a in gastric cancer directly targ ......" | 22020746 | Flow cytometry; Western blot; Luciferase |
hsa-miR-146a-5p | gastric cancer | Apoptosis pathway | "Celastrol induces apoptosis of gastric cancer cell ......" | 23706078 | Western blot; Luciferase |
hsa-miR-146a-5p | gastric cancer | Apoptosis pathway | "MicroRNA 146a enhances Helicobacter pylori induced ......" | 25081668 | |
hsa-miR-146a-5p | liver cancer | Apoptosis pathway | "miR 146a suppresses the sensitivity to interferon ......" | 21982769 | |
hsa-miR-146a-5p | liver cancer | Apoptosis pathway | "Synergistic effect of MiR 146a mimic and cetuximab ......" | 24895573 | Western blot |
hsa-miR-146a-5p | lung cancer | Apoptosis pathway | "Effect and molecular mechanism of mir 146a on prol ......" | 27569893 | Luciferase; Western blot; MTT assay |
hsa-miR-146a-5p | lung squamous cell cancer | Apoptosis pathway | "miR 146a inhibits cell growth cell migration and i ......" | 23555954 | |
hsa-miR-146a-5p | lung squamous cell cancer | Epithelial mesenchymal transition pathway | "MicroRNA 146a inhibits epithelial mesenchymal tran ......" | 26238771 | Cell migration assay; Luciferase |
hsa-miR-146a-5p | lymphoma | Apoptosis pathway | "MicroRNA 146a downregulates NFκB activity via tar ......" | 21610143 | |
hsa-miR-146a-5p | melanoma | Notch signaling pathway | "miR 146a promotes the initiation and progression o ......" | 24550252 | |
hsa-miR-146a-5p | ovarian cancer | Apoptosis pathway | "miR 146a Inhibits Proliferation and Enhances Chemo ......" | 27131313 | |
hsa-miR-146a-5p | prostate cancer | Apoptosis pathway | "Demethylation of the miR 146a promoter by 5 Aza 2' ......" | 24885368 | Western blot; Cell Proliferation Assay |
hsa-miR-146a-5p | prostate cancer | Apoptosis pathway | "Hsa miR 146a 5p modulates androgen independent pro ......" | 26306811 | Western blot; Luciferase |
hsa-miR-146a-5p | thyroid cancer | Apoptosis pathway | "Nuclear factor kappaB contributes to anaplastic th ......" | 20061417 | |
hsa-miR-146a-5p | thyroid cancer | Apoptosis pathway | "MicroRNA 146a targets PRKCE to modulate papillary ......" | 23457043 | Luciferase |
Reported cancer prognosis affected by hsa-miR-146a-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-146a-5p | bladder cancer | recurrence | "We found that miR-146a rs2910164 C allele was asso ......" | 22846912 | |
hsa-miR-146a-5p | bladder cancer | staging; metastasis | "At present inconsistent association between single ......" | 26458899 | |
hsa-miR-146a-5p | breast cancer | metastasis | "Breast cancer metastasis suppressor 1 up regulates ......" | 19190326 | |
hsa-miR-146a-5p | breast cancer | metastasis | "MicroRNA arrays were done comparing small RNAs tha ......" | 19585508 | |
hsa-miR-146a-5p | breast cancer | tumorigenesis | "Microarray-based techniques are being useful to ob ......" | 22167321 | |
hsa-miR-146a-5p | breast cancer | tumorigenesis | "MicroRNA-146a and -146b are encoded by two differe ......" | 22350993 | |
hsa-miR-146a-5p | breast cancer | drug resistance | "We identified un-described network clusters that c ......" | 23270413 | |
hsa-miR-146a-5p | breast cancer | cell migration; metastasis | "TRAIL induced miR 146a expression suppresses CXCR4 ......" | 23647548 | |
hsa-miR-146a-5p | breast cancer | drug resistance; progression | "Overexpression of miR 146a in basal like breast ca ......" | 25123132 | RNAi |
hsa-miR-146a-5p | breast cancer | poor survival | "BRCA1 regulation of epidermal growth factor recept ......" | 25417703 | |
hsa-miR-146a-5p | breast cancer | metastasis; progression | "Aberrant plasma levels of circulating miR 16 miR 1 ......" | 26033453 | |
hsa-miR-146a-5p | breast cancer | poor survival | "miR 146a and miR 638 in BRCA1 deficient triple neg ......" | 26835710 | |
hsa-miR-146a-5p | breast cancer | cell migration | "MicroRNA 146a inhibits cell migration and invasion ......" | 27175941 | Luciferase |
hsa-miR-146a-5p | breast cancer | metastasis; progression; poor survival | "We evaluated the expression levels of miR-21 miR-1 ......" | 27197674 | |
hsa-miR-146a-5p | breast cancer | poor survival | "Functional SNP in stem of mir 146a affects Her2 st ......" | 27434289 | |
hsa-miR-146a-5p | cervical and endocervical cancer | tumorigenesis | "Using miRNA array analyses for age-matched normal ......" | 18596939 | |
hsa-miR-146a-5p | cervical and endocervical cancer | progression | "The oncogenic proteins E6 E7 and E5 expressed by H ......" | 23189617 | |
hsa-miR-146a-5p | cervical and endocervical cancer | tumor size; progression | "The occurrence of cervical cancer in Uygur women i ......" | 26464690 | |
hsa-miR-146a-5p | colon cancer | staging | "To present proof-of-principle application for empl ......" | 23741026 | |
hsa-miR-146a-5p | colon cancer | differentiation; staging; tumor size; poor survival | "Expression of miR 146a in colon cancer and its sig ......" | 24670457 | Flow cytometry |
hsa-miR-146a-5p | colorectal cancer | poor survival; worse prognosis | "A miR 146a polymorphism rs2910164 predicts risk of ......" | 23898084 | |
hsa-miR-146a-5p | colorectal cancer | differentiation | "We genotyped the polymorphism of two common miRNA ......" | 24136745 | |
hsa-miR-146a-5p | colorectal cancer | tumorigenesis | "Association of a genetic variant in microRNA 146a ......" | 24740563 | |
hsa-miR-146a-5p | colorectal cancer | tumorigenesis; progression | "Target resequencing to identify microRNA associate ......" | 26813595 | |
hsa-miR-146a-5p | esophageal cancer | staging | "Five polymorphisms miR-146a rs2910164 miR-196a2 rs ......" | 24288122 | |
hsa-miR-146a-5p | esophageal cancer | progression | "Prognostic and diagnostic potential of miR 146a in ......" | 26794279 | |
hsa-miR-146a-5p | gastric cancer | metastasis | "Differential expression of miRNAs was studied usin ......" | 20726036 | |
hsa-miR-146a-5p | gastric cancer | progression; differentiation; tumor size; poor survival | "MicroRNA 146a is down regulated in gastric cancer ......" | 21347720 | MTT assay |
hsa-miR-146a-5p | gastric cancer | worse prognosis; metastasis; poor survival | "Clinical significance of miR 146a in gastric cance ......" | 21632853 | |
hsa-miR-146a-5p | gastric cancer | staging | "A functional polymorphism in Pre miR 146a is assoc ......" | 22455393 | |
hsa-miR-146a-5p | gastric cancer | metastasis | "microRNA 146a targets the L1 cell adhesion molecul ......" | 22711166 | Transwell assay; Wound Healing Assay; Western blot; Luciferase |
hsa-miR-146a-5p | gastric cancer | poor survival | "We evaluated the association between three SNPs rs ......" | 22993637 | |
hsa-miR-146a-5p | gastric cancer | metastasis | "MicroRNA 146a acts as a metastasis suppressor in g ......" | 23435376 | Luciferase |
hsa-miR-146a-5p | gastric cancer | metastasis; staging | "In a pilot study serum levels of miR-21 miR-27a mi ......" | 23806809 | |
hsa-miR-146a-5p | gastric cancer | worse prognosis | "The aim of the study was to investigated whether t ......" | 24379078 | |
hsa-miR-146a-5p | gastric cancer | tumorigenesis; staging; metastasis; differentiation | "The clinical significance of downregulation of mir ......" | 24805774 | |
hsa-miR-146a-5p | gastric cancer | metastasis | "MicroRNA 146a enhances Helicobacter pylori induced ......" | 25081668 | |
hsa-miR-146a-5p | gastric cancer | staging; worse prognosis | "Common single-nucleotide polymorphisms SNPs in pre ......" | 25202115 | |
hsa-miR-146a-5p | gastric cancer | worse prognosis | "Association of the miR 146a rs2910164 polymorphism ......" | 27267319 | |
hsa-miR-146a-5p | gastric cancer | progression | "In this study BARF1-expressing stomach cancer cell ......" | 27438138 | |
hsa-miR-146a-5p | glioblastoma | poor survival | "Induction of microRNA 146a is involved in curcumin ......" | 26239619 | |
hsa-miR-146a-5p | head and neck cancer | metastasis | "Characterization of miR 146a and miR 155 in blood ......" | 26621153 | |
hsa-miR-146a-5p | kidney renal cell cancer | staging; poor survival | "We genotyped four common miRNA SNPs i.e miR-146a r ......" | 24681820 | |
hsa-miR-146a-5p | kidney renal cell cancer | worse prognosis; poor survival | "Effect of a functional polymorphism in the pre miR ......" | 26323945 | |
hsa-miR-146a-5p | kidney renal cell cancer | metastasis | "Integrated microRNA and mRNA Signature Associated ......" | 26859141 | |
hsa-miR-146a-5p | liver cancer | tumorigenesis | "No association of pre microRNA 146a rs2910164 poly ......" | 21807077 | |
hsa-miR-146a-5p | liver cancer | drug resistance | "miR 146a suppresses the sensitivity to interferon ......" | 21982769 | |
hsa-miR-146a-5p | liver cancer | drug resistance | "The cell viability MTT assay was used to detect dr ......" | 23229111 | MTT assay |
hsa-miR-146a-5p | liver cancer | staging; metastasis; tumorigenesis | "Expression and clinicopathological significance of ......" | 24172202 | |
hsa-miR-146a-5p | liver cancer | malignant trasformation | "Synergistic effect of MiR 146a mimic and cetuximab ......" | 24895573 | Western blot |
hsa-miR-146a-5p | liver cancer | immune resistance | "miR 146a is directly regulated by STAT3 in human h ......" | 25607648 | Luciferase |
hsa-miR-146a-5p | liver cancer | metastasis; progression; tumorigenesis; worse prognosis | "microRNA 146a inhibits cancer metastasis by downre ......" | 25608619 | Luciferase |
hsa-miR-146a-5p | liver cancer | progression | "Association between microRNA 196A2 and microRNA 14 ......" | 26529280 | |
hsa-miR-146a-5p | lung cancer | tumorigenesis | "Other significantly differentiated miR families in ......" | 23035181 | |
hsa-miR-146a-5p | lung cancer | poor survival | "Polymorphisms of microRNA sequences or binding sit ......" | 23613771 | |
hsa-miR-146a-5p | lung cancer | tumorigenesis | "A common polymorphism in pre microRNA 146a is asso ......" | 24144839 | |
hsa-miR-146a-5p | lung squamous cell cancer | recurrence; worse prognosis | "The prognostic impact of microRNA sequence polymor ......" | 22818121 | |
hsa-miR-146a-5p | lung squamous cell cancer | cell migration; progression; malignant trasformation; staging; metastasis; poor survival | "miR 146a inhibits cell growth cell migration and i ......" | 23555954 | |
hsa-miR-146a-5p | lung squamous cell cancer | worse prognosis | "microRNA 146 up regulation predicts the prognosis ......" | 24448024 | |
hsa-miR-146a-5p | lung squamous cell cancer | staging; metastasis; poor survival; drug resistance | "Serum levels of miR 19b and miR 146a as prognostic ......" | 24531034 | |
hsa-miR-146a-5p | lung squamous cell cancer | malignant trasformation | "MicroRNA 146a rs2910164 polymorphism is associated ......" | 25154761 | |
hsa-miR-146a-5p | lung squamous cell cancer | progression | "MicroRNA 146a inhibits epithelial mesenchymal tran ......" | 26238771 | Cell migration assay; Luciferase |
hsa-miR-146a-5p | lymphoma | staging | "Herein we used a global quantitative real-time pol ......" | 25503151 | |
hsa-miR-146a-5p | melanoma | malignant trasformation | "The rs2910164 G>C polymorphism in microRNA 146a is ......" | 23222547 | |
hsa-miR-146a-5p | melanoma | progression | "miR 146a promotes the initiation and progression o ......" | 24550252 | |
hsa-miR-146a-5p | melanoma | progression; metastasis; recurrence | "miR 146a Exerts Differential Effects on Melanoma G ......" | 26965144 | |
hsa-miR-146a-5p | melanoma | progression; metastasis; recurrence | "miR 146a Exerts Differential Effects on Melanoma G ......" | 27311960 | |
hsa-miR-146a-5p | ovarian cancer | metastasis; poor survival | "We analyzed the miRNA expression profiles of prima ......" | 23554878 | |
hsa-miR-146a-5p | ovarian cancer | progression; poor survival | "By analyzing multidimensional datasets of ovarian ......" | 25537514 | |
hsa-miR-146a-5p | prostate cancer | metastasis | "Loss of mir 146a function in hormone refractory pr ......" | 18174313 | Fluorescent in situ hybridization |
hsa-miR-146a-5p | prostate cancer | progression | "MiR 146a suppresses tumor growth and progression b ......" | 22161865 | Colony formation; MTT assay |
hsa-miR-146a-5p | prostate cancer | progression | "Aberrant expressions of some miRNAs like miR-221/2 ......" | 24386864 | |
hsa-miR-146a-5p | prostate cancer | metastasis | "We identify that TGFβ1-related miR-143 miR-145 mi ......" | 24763824 | |
hsa-miR-146a-5p | prostate cancer | progression; staging | "Demethylation of the miR 146a promoter by 5 Aza 2' ......" | 24885368 | Western blot; Cell Proliferation Assay |
hsa-miR-146a-5p | prostate cancer | staging; drug resistance | "Following global miRNA profiling of cell line mode ......" | 25053345 | |
hsa-miR-146a-5p | prostate cancer | progression | "Association between genetic variant in hsa miR 146 ......" | 25084752 | |
hsa-miR-146a-5p | prostate cancer | motility | "miR 146a functions as a tumor suppressor in prosta ......" | 25214035 | Colony formation; Luciferase |
hsa-miR-146a-5p | thyroid cancer | tumorigenesis | "MicroRNA miRNA microarray analysis has consistentl ......" | 18587330 | |
hsa-miR-146a-5p | thyroid cancer | tumorigenesis | "Our review of the literature strongly supports thi ......" | 21865360 | |
hsa-miR-146a-5p | thyroid cancer | poor survival | "MicroRNA 146a targets PRKCE to modulate papillary ......" | 23457043 | Luciferase |
hsa-miR-146a-5p | thyroid cancer | staging; metastasis; tumorigenesis | "Associations of miR 146a and miR 146b expression a ......" | 25524940 |
Reported gene related to hsa-miR-146a-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-146a-5p | breast cancer | EGFR | "Furthermore the expressions of bax and cleaved-cas ......" | 25596948 |
hsa-miR-146a-5p | breast cancer | EGFR | "Here we report a previously unrecognized posttrans ......" | 25417703 |
hsa-miR-146a-5p | gastric cancer | EGFR | "The regulation of EGFR and IRAK1 by miR-146a was e ......" | 21632853 |
hsa-miR-146a-5p | liver cancer | EGFR | "Furthermore western blot showed that miR-146a mimi ......" | 24895573 |
hsa-miR-146a-5p | lung squamous cell cancer | EGFR | "In functional experiments miR-146a suppressed cell ......" | 23555954 |
hsa-miR-146a-5p | pancreatic cancer | EGFR | "Interestingly re-expression of miR-146a inhibited ......" | 25242818 |
hsa-miR-146a-5p | pancreatic cancer | EGFR | "Deregulation of miR 146a expression in a mouse mod ......" | 24839931 |
hsa-miR-146a-5p | prostate cancer | EGFR | "MiR 146a suppresses tumor growth and progression b ......" | 22161865 |
hsa-miR-146a-5p | colorectal cancer | CTSG | "Moreover a multivariate analysis showed that the C ......" | 23898084 |
hsa-miR-146a-5p | liver cancer | CTSG | "No significant relationships were observed between ......" | 21624236 |
hsa-miR-146a-5p | liver cancer | CTSG | "However we found that patients with genotype CG of ......" | 21861697 |
hsa-miR-146a-5p | lung cancer | CTSG | "For miR-146a rs2910164 individuals carrying hetero ......" | 26973201 |
hsa-miR-146a-5p | lung cancer | CTSG | "Conversely CG genotype of miR-146a appeared associ ......" | 21902575 |
hsa-miR-146a-5p | lung cancer | CTSG | "In line with this result the level of miR-146a exp ......" | 24144839 |
hsa-miR-146a-5p | melanoma | CTSG | "However there was no significant difference betwee ......" | 23222547 |
hsa-miR-146a-5p | breast cancer | BRCA1 | "We report here the involvement of miR-146a and miR ......" | 21472990 |
hsa-miR-146a-5p | breast cancer | BRCA1 | "Here we report a previously unrecognized posttrans ......" | 25417703 |
hsa-miR-146a-5p | breast cancer | BRCA1 | "miR 146a and miR 638 in BRCA1 deficient triple neg ......" | 26835710 |
hsa-miR-146a-5p | liver cancer | BRCA1 | "Furthermore we revealed that miR-146a promoted the ......" | 23671131 |
hsa-miR-146a-5p | ovarian cancer | BRCA1 | "The predicted miR-146a target genes include BRCA1 ......" | 18660546 |
hsa-miR-146a-5p | breast cancer | NFKB1 | "Expression of microRNA 146 suppresses NF kappaB ac ......" | 18504431 |
hsa-miR-146a-5p | gastric cancer | NFKB1 | "By targeting components of several NF-kappaB-activ ......" | 22992343 |
hsa-miR-146a-5p | sarcoma | NFKB1 | "Reporter studies identified two NF-kappaB sites in ......" | 20023696 |
hsa-miR-146a-5p | thyroid cancer | NFKB1 | "Our results show that NF-kappaB contributes to ana ......" | 20061417 |
hsa-miR-146a-5p | acute myeloid leukemia | CXCR4 | "MicroRNA 146a and AMD3100 two ways to control CXCR ......" | 22829170 |
hsa-miR-146a-5p | breast cancer | CXCR4 | "TRAIL induced miR 146a expression suppresses CXCR4 ......" | 23647548 |
hsa-miR-146a-5p | sarcoma | CXCR4 | "Suppression of CXCR4 by KSHV and K13 was associate ......" | 20023696 |
hsa-miR-146a-5p | bladder cancer | IRAK1 | "Functional analysis revealed that miR-146a rs29101 ......" | 22846912 |
hsa-miR-146a-5p | gastric cancer | IRAK1 | "The regulation of EGFR and IRAK1 by miR-146a was e ......" | 21632853 |
hsa-miR-146a-5p | pancreatic cancer | IRAK1 | "Interestingly re-expression of miR-146a inhibited ......" | 25242818 |
hsa-miR-146a-5p | breast cancer | NFASC | "53BP1 functions as a tumor suppressor in breast ca ......" | 23027628 |
hsa-miR-146a-5p | breast cancer | NFASC | "Expression of microRNA 146 suppresses NF kappaB ac ......" | 18504431 |
hsa-miR-146a-5p | gastric cancer | NFASC | "Celastrol induces apoptosis of gastric cancer cell ......" | 23706078 |
hsa-miR-146a-5p | gastric cancer | PTGS2 | "We found that overexpression of microRNA-146a by t ......" | 25081668 |
hsa-miR-146a-5p | lung cancer | PTGS2 | "The protein expression level of COX-2 in A549 cell ......" | 26902276 |
hsa-miR-146a-5p | lung cancer | PTGS2 | "Regulation of COX 2 expression by miR 146a in lung ......" | 25047043 |
hsa-miR-146a-5p | gastric cancer | SMAD4 | "SMAD4 was identified as a miR-146a target and was ......" | 27438138 |
hsa-miR-146a-5p | gastric cancer | SMAD4 | "Increased miR 146a in gastric cancer directly targ ......" | 22020746 |
hsa-miR-146a-5p | liver cancer | SMAD4 | "The results indicated that miR-146a regulated the ......" | 21982769 |
hsa-miR-146a-5p | gastric cancer | UHRF1 | "We identified and verified miR-146a and miR-146b a ......" | 23982143 |
hsa-miR-146a-5p | gastric cancer | UHRF1 | "The correlation between miR 146a C/G polymorphism ......" | 26896831 |
hsa-miR-146a-5p | kidney renal cell cancer | UHRF1 | "The interaction between miR-146a-5p and their targ ......" | 26859141 |
hsa-miR-146a-5p | breast cancer | BRMS1 | "BRMS1 significantly up-regulates miR-146a by 6- to ......" | 19190326 |
hsa-miR-146a-5p | breast cancer | BRMS1 | "Concurrently BRMS1 increased expression of metasta ......" | 19585508 |
hsa-miR-146a-5p | breast cancer | CASP3 | "All the results demonstrated that quercetin exhibi ......" | 25596948 |
hsa-miR-146a-5p | prostate cancer | CASP3 | "Moreover caspase 3 activity was stimulated by miR- ......" | 26306811 |
hsa-miR-146a-5p | kidney renal cell cancer | IL8 | "The interaction between miR-146a-5p and their targ ......" | 26859141 |
hsa-miR-146a-5p | lung cancer | IL8 | "The mRNA expression levels of IL-8 MCP-1 and GRO-Î ......" | 26902276 |
hsa-miR-146a-5p | colorectal cancer | NUMB | "miR-146a targets Numb to stabilize β-catenin whic ......" | 24561623 |
hsa-miR-146a-5p | melanoma | NUMB | "We show these oncogenic activities are due to miR- ......" | 24550252 |
hsa-miR-146a-5p | prostate cancer | ROCK1 | "In mechanic analyses we found that miR-146a inhibi ......" | 26306811 |
hsa-miR-146a-5p | prostate cancer | ROCK1 | "Transfection of mir-146a which perpetually express ......" | 18174313 |
hsa-miR-146a-5p | bladder cancer | TRAF6 | "Functional analysis revealed that miR-146a rs29101 ......" | 22846912 |
hsa-miR-146a-5p | lymphoma | TRAF6 | "MicroRNA 146a downregulates NFκB activity via tar ......" | 21610143 |
hsa-miR-146a-5p | gastric cancer | ABCC4 | "Using target prediction algorithms luciferase repo ......" | 22020746 |
hsa-miR-146a-5p | liver cancer | APC | "The expression levels of genes including miR-146a ......" | 25608619 |
hsa-miR-146a-5p | breast cancer | AR | "To study the cellular response to miR-146a upregul ......" | 25123132 |
hsa-miR-146a-5p | cervical and endocervical cancer | ARHGEF15 | "The oncogenic proteins E6 E7 and E5 expressed by H ......" | 23189617 |
hsa-miR-146a-5p | breast cancer | ARHGEF7 | "In this study miR-146a and miR-222 were shown to b ......" | 26689540 |
hsa-miR-146a-5p | thyroid cancer | ATM | "Importantly the miR-146a resulted in overexpressio ......" | 20061417 |
hsa-miR-146a-5p | breast cancer | BAX | "Furthermore the expressions of bax and cleaved-cas ......" | 25596948 |
hsa-miR-146a-5p | melanoma | BRAF | "In this study we identify a microRNA miR-146a that ......" | 24550252 |
hsa-miR-146a-5p | ovarian cancer | BRCA2 | "The predicted miR-146a target genes include BRCA1 ......" | 18660546 |
hsa-miR-146a-5p | breast cancer | CCDC6 | "The SNP rs2910164 in miR146a a G to C polymorphism ......" | 26476291 |
hsa-miR-146a-5p | lung cancer | CCL2 | "The mRNA expression levels of IL-8 MCP-1 and GRO-Î ......" | 26902276 |
hsa-miR-146a-5p | lung cancer | CSE | "Under the premise of smoke inhalation injury to ex ......" | 26902276 |
hsa-miR-146a-5p | pancreatic cancer | DCX | "Aberrant elevated microRNA 146a in dendritic cells ......" | 22311263 |
hsa-miR-146a-5p | lung cancer | EGF | "MiR-146a down-regulates epidermal growth factor re ......" | 24144839 |
hsa-miR-146a-5p | breast cancer | ERBB2 | "Functional SNP in stem of mir 146a affects Her2 st ......" | 27434289 |
hsa-miR-146a-5p | lung cancer | FAF2 | "Under the premise of smoke inhalation injury to ex ......" | 26902276 |
hsa-miR-146a-5p | lung cancer | FAS | "Effects of microRNA 146a on Fas associated factor ......" | 26902276 |
hsa-miR-146a-5p | gastric cancer | GAST | "The expression of miR-146a was evaluated by quanti ......" | 22992343 |
hsa-miR-146a-5p | gastric cancer | GCA | "The single nucleotide polymorphism SNP rs2910164 G ......" | 27105532 |
hsa-miR-146a-5p | thyroid cancer | GRP | "The miR-146a polymorphisms were shown to be signif ......" | 26722556 |
hsa-miR-146a-5p | prostate cancer | IBSP | "The methylation levels of miR-146a promoter region ......" | 24885368 |
hsa-miR-146a-5p | melanoma | IGKV3-7 | "Upregulation of miR-21 and miR-146a was also detec ......" | 25951497 |
hsa-miR-146a-5p | breast cancer | IL6 | "We investigated expressions of miR-146a miR-146b a ......" | 26406414 |
hsa-miR-146a-5p | lung squamous cell cancer | INSR | "MicroRNA 146a inhibits epithelial mesenchymal tran ......" | 26238771 |
hsa-miR-146a-5p | gastric cancer | L1CAM | "Taken together our results provide evidence that m ......" | 22711166 |
hsa-miR-146a-5p | pancreatic cancer | MIA | "The present study identifies a series of miRNAs wh ......" | 23073476 |
hsa-miR-146a-5p | lung cancer | MIF | "Effect and molecular mechanism of mir 146a on prol ......" | 27569893 |
hsa-miR-146a-5p | breast cancer | MMP16 | "Catalpol suppresses proliferation and facilitates ......" | 26458573 |
hsa-miR-146a-5p | prostate cancer | MMP2 | "Also miR-146a inhibited the expression of MMP2 one ......" | 22161865 |
hsa-miR-146a-5p | head and neck cancer | MMP8 | "Odds ratios ORs with 95% confidence interval CIs w ......" | 26277865 |
hsa-miR-146a-5p | breast cancer | MTSS1 | "Breast cancer metastasis suppressor 1 up regulates ......" | 19190326 |
hsa-miR-146a-5p | kidney renal cell cancer | NOA1 | "Loss of inducible nitric oxide synthase expression ......" | 20709800 |
hsa-miR-146a-5p | gastric cancer | NOL3 | "We also found that miR-146a inhibited apoptosis of ......" | 22020746 |
hsa-miR-146a-5p | kidney renal cell cancer | NOS2 | "This effect is mediated by the microRNA miR-146a a ......" | 20709800 |
hsa-miR-146a-5p | melanoma | NRAS | "In this study we identify a microRNA miR-146a that ......" | 24550252 |
hsa-miR-146a-5p | melanoma | OCM | "Both MUM2B and OCM1 cells expressed and secreted N ......" | 27565163 |
hsa-miR-146a-5p | gastric cancer | PDC | "To investigate the association between the polymor ......" | 26896831 |
hsa-miR-146a-5p | liver cancer | PDGFRA | "MiR 146a enhances angiogenic activity of endotheli ......" | 23671131 |
hsa-miR-146a-5p | prostate cancer | PDZD2 | "We demonstrated that miR-146a was down-regulated i ......" | 26306811 |
hsa-miR-146a-5p | thyroid cancer | PRKCE | "MicroRNA 146a targets PRKCE to modulate papillary ......" | 23457043 |
hsa-miR-146a-5p | thyroid cancer | PTTG1 | "Are pre miR 146a and PTTG1 associated with papilla ......" | 24145614 |
hsa-miR-146a-5p | prostate cancer | RAC1 | "miR 146a functions as a tumor suppressor in prosta ......" | 25214035 |
hsa-miR-146a-5p | thyroid cancer | RARB | "Direct interaction between miRs and RARB was deter ......" | 27011326 |
hsa-miR-146a-5p | breast cancer | RHOA | "MicroRNA 146a inhibits cell migration and invasion ......" | 27175941 |
hsa-miR-146a-5p | ovarian cancer | ROS1 | "Overexpression of miR-146a increased the reactive ......" | 27131313 |
hsa-miR-146a-5p | prostate cancer | RTCA | "Effects of miR-146a on cell growth and migration w ......" | 25214035 |
hsa-miR-146a-5p | colorectal cancer | SCD | "miR-146a targets Numb to stabilize β-catenin whic ......" | 24561623 |
hsa-miR-146a-5p | lymphoma | SCYL1 | "These results suggest that miR-146a might function ......" | 21610143 |
hsa-miR-146a-5p | colorectal cancer | SNAI1 | "MicroRNA 146a directs the symmetric division of Sn ......" | 24561623 |
hsa-miR-146a-5p | ovarian cancer | SOD2 | "miR 146a Inhibits Proliferation and Enhances Chemo ......" | 27131313 |
hsa-miR-146a-5p | liver cancer | STAT3 | "miR 146a is directly regulated by STAT3 in human h ......" | 25607648 |
hsa-miR-146a-5p | thyroid cancer | THRB | "Direct interaction with THRB was shown for miR-21 ......" | 21159845 |
hsa-miR-146a-5p | lymphoma | TNF | "TNF receptor-associated factor 6 a target of miR-1 ......" | 21610143 |
hsa-miR-146a-5p | breast cancer | TP53 | "Overexpression of miR 146a in basal like breast ca ......" | 25123132 |
hsa-miR-146a-5p | breast cancer | TP53BP1 | "53BP1 functions as a tumor suppressor in breast ca ......" | 23027628 |
hsa-miR-146a-5p | prostate cancer | TUBA1B | "Our findings suggest that ubiquitous loss of miR-1 ......" | 22161865 |
hsa-miR-146a-5p | liver cancer | VEGFA | "microRNA 146a inhibits cancer metastasis by downre ......" | 25608619 |
hsa-miR-146a-5p | gastric cancer | WASF2 | "MicroRNA 146a acts as a metastasis suppressor in g ......" | 23435376 |
hsa-miR-146a-5p | breast cancer | YARS | "We compared the expression levels of breast cancer ......" | 23898484 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-146a-5p | BGLAP | 9 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; OV; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.071; TCGA BRCA -0.135; TCGA HNSC -0.142; TCGA LGG -0.097; TCGA LUAD -0.137; TCGA LUSC -0.083; TCGA OV -0.089; TCGA THCA -0.066; TCGA STAD -0.128 |
hsa-miR-146a-5p | ERBB4 | 10 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; OV; SARC; THCA; STAD | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.27; TCGA BRCA -0.772; TCGA CESC -0.46; TCGA KIRC -1.009; TCGA KIRP -1.242; TCGA LGG -0.141; TCGA OV -0.2; TCGA SARC -0.191; TCGA THCA -0.236; TCGA STAD -0.287 |
hsa-miR-146a-5p | MTUS2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.329; TCGA BRCA -0.184; TCGA CESC -0.388; TCGA ESCA -0.192; TCGA HNSC -0.141; TCGA KIRC -0.218; TCGA KIRP -0.319; TCGA OV -0.234; TCGA PAAD -0.516; TCGA SARC -0.631; TCGA STAD -0.756; TCGA UCEC -0.378 |
hsa-miR-146a-5p | SMAD4 | 12 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.082; TCGA CESC -0.097; TCGA ESCA -0.085; TCGA KIRC -0.069; TCGA KIRP -0.09; TCGA LGG -0.123; TCGA LUAD -0.086; TCGA PAAD -0.117; TCGA PRAD -0.074; TCGA SARC -0.157; TCGA STAD -0.111; TCGA UCEC -0.103 |
hsa-miR-146a-5p | PRKAA2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.298; TCGA BRCA -0.303; TCGA CESC -0.51; TCGA COAD -0.879; TCGA ESCA -0.464; TCGA KIRC -0.224; TCGA KIRP -0.157; TCGA LGG -0.136; TCGA LUSC -0.381; TCGA PRAD -0.097; TCGA SARC -0.61; TCGA THCA -0.176; TCGA STAD -0.857; TCGA UCEC -0.153 |
hsa-miR-146a-5p | RGS5 | 10 cancers: BLCA; BRCA; COAD; KIRP; LIHC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.206; TCGA BRCA -0.245; TCGA COAD -0.362; TCGA KIRP -0.333; TCGA LIHC -0.135; TCGA OV -0.059; TCGA SARC -0.168; TCGA THCA -0.319; TCGA STAD -0.316; TCGA UCEC -0.081 |
hsa-miR-146a-5p | FZD3 | 11 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.159; TCGA CESC -0.373; TCGA HNSC -0.122; TCGA KIRC -0.196; TCGA KIRP -0.124; TCGA LUAD -0.252; TCGA LUSC -0.147; TCGA PAAD -0.197; TCGA THCA -0.11; TCGA STAD -0.196; TCGA UCEC -0.066 |
hsa-miR-146a-5p | THRB | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.285; TCGA BRCA -0.186; TCGA CESC -0.169; TCGA COAD -0.471; TCGA HNSC -0.171; TCGA KIRC -0.41; TCGA KIRP -0.332; TCGA LIHC -0.123; TCGA LUSC -0.221; TCGA PRAD -0.066; TCGA SARC -0.303; TCGA STAD -0.367; TCGA UCEC -0.46 |
hsa-miR-146a-5p | ZNF540 | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; OV; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.087; TCGA BRCA -0.056; TCGA COAD -0.131; TCGA KIRC -0.233; TCGA KIRP -0.183; TCGA LGG -0.146; TCGA LIHC -0.067; TCGA OV -0.211; TCGA SARC -0.269; TCGA THCA -0.235; TCGA UCEC -0.152 |
hsa-miR-146a-5p | IBTK | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LIHC; LUAD; OV; PAAD | MirTarget | TCGA BLCA -0.051; TCGA BRCA -0.11; TCGA CESC -0.079; TCGA KIRC -0.095; TCGA KIRP -0.087; TCGA LIHC -0.086; TCGA LUAD -0.09; TCGA OV -0.052; TCGA PAAD -0.075 |
hsa-miR-146a-5p | ZNF253 | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; OV; PAAD; SARC; THCA | MirTarget | TCGA BLCA -0.077; TCGA KIRC -0.095; TCGA KIRP -0.15; TCGA LGG -0.069; TCGA LIHC -0.068; TCGA OV -0.129; TCGA PAAD -0.093; TCGA SARC -0.124; TCGA THCA -0.124 |
hsa-miR-146a-5p | DCAF5 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUSC; OV; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.095; TCGA BRCA -0.098; TCGA CESC -0.076; TCGA ESCA -0.099; TCGA HNSC -0.116; TCGA KIRP -0.082; TCGA LGG -0.07; TCGA LUSC -0.077; TCGA OV -0.058; TCGA THCA -0.05; TCGA STAD -0.108; TCGA UCEC -0.07 |
hsa-miR-146a-5p | ARL10 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.104; TCGA CESC -0.185; TCGA COAD -0.437; TCGA ESCA -0.293; TCGA HNSC -0.099; TCGA KIRP -0.132; TCGA LUSC -0.141; TCGA SARC -0.185; TCGA STAD -0.28; TCGA UCEC -0.262 |
hsa-miR-146a-5p | DTNA | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.173; TCGA CESC -0.171; TCGA COAD -0.628; TCGA ESCA -0.542; TCGA HNSC -0.222; TCGA LUSC -0.188; TCGA OV -0.233; TCGA PAAD -0.303; TCGA SARC -0.273; TCGA STAD -0.692; TCGA UCEC -0.315 |
hsa-miR-146a-5p | ZNF512B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LIHC; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.078; TCGA BRCA -0.051; TCGA CESC -0.084; TCGA COAD -0.295; TCGA ESCA -0.257; TCGA LGG -0.068; TCGA LIHC -0.065; TCGA LUAD -0.089; TCGA OV -0.059; TCGA PAAD -0.092; TCGA SARC -0.16; TCGA THCA -0.084; TCGA STAD -0.146; TCGA UCEC -0.082 |
hsa-miR-146a-5p | ZNF10 | 10 cancers: BLCA; KIRC; KIRP; LIHC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.15; TCGA KIRC -0.226; TCGA KIRP -0.176; TCGA LIHC -0.065; TCGA OV -0.157; TCGA PAAD -0.156; TCGA SARC -0.221; TCGA THCA -0.169; TCGA STAD -0.213; TCGA UCEC -0.086 |
hsa-miR-146a-5p | LANCL1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.06; TCGA BRCA -0.086; TCGA CESC -0.071; TCGA COAD -0.068; TCGA ESCA -0.068; TCGA HNSC -0.065; TCGA KIRC -0.146; TCGA KIRP -0.148; TCGA LIHC -0.078; TCGA LUAD -0.064; TCGA LUSC -0.063; TCGA OV -0.085; TCGA PRAD -0.064; TCGA SARC -0.17; TCGA STAD -0.099; TCGA UCEC -0.112 |
hsa-miR-146a-5p | SORT1 | 11 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.103; TCGA BRCA -0.073; TCGA CESC -0.134; TCGA KIRC -0.33; TCGA KIRP -0.138; TCGA LUAD -0.067; TCGA LUSC -0.123; TCGA PAAD -0.084; TCGA SARC -0.172; TCGA THCA -0.107; TCGA STAD -0.15 |
hsa-miR-146a-5p | RHOBTB3 | 13 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.103; TCGA BRCA -0.141; TCGA CESC -0.328; TCGA KIRC -0.491; TCGA KIRP -0.465; TCGA LGG -0.084; TCGA LIHC -0.089; TCGA LUAD -0.114; TCGA OV -0.149; TCGA PAAD -0.154; TCGA PRAD -0.074; TCGA STAD -0.333; TCGA UCEC -0.149 |
hsa-miR-146a-5p | MARK4 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.08; TCGA BRCA -0.074; TCGA CESC -0.079; TCGA ESCA -0.119; TCGA HNSC -0.159; TCGA LGG -0.08; TCGA LIHC -0.051; TCGA LUAD -0.109; TCGA LUSC -0.059; TCGA OV -0.084; TCGA PAAD -0.057; TCGA PRAD -0.057; TCGA STAD -0.063; TCGA UCEC -0.071 |
hsa-miR-146a-5p | ANKS1A | 12 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.063; TCGA COAD -0.069; TCGA ESCA -0.058; TCGA KIRC -0.214; TCGA KIRP -0.157; TCGA LUAD -0.094; TCGA LUSC -0.123; TCGA OV -0.084; TCGA SARC -0.096; TCGA THCA -0.088; TCGA STAD -0.212; TCGA UCEC -0.084 |
hsa-miR-146a-5p | PLXNA2 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LUSC; PAAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.149; TCGA BRCA -0.065; TCGA HNSC -0.081; TCGA KIRP -0.256; TCGA LUSC -0.141; TCGA PAAD -0.14; TCGA SARC -0.128; TCGA THCA -0.127; TCGA STAD -0.084 |
hsa-miR-146a-5p | MTMR3 | 9 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUSC; PAAD; PRAD; SARC | mirMAP | TCGA BLCA -0.074; TCGA CESC -0.057; TCGA ESCA -0.083; TCGA KIRC -0.066; TCGA KIRP -0.106; TCGA LUSC -0.105; TCGA PAAD -0.092; TCGA PRAD -0.056; TCGA SARC -0.08 |
hsa-miR-146a-5p | DIDO1 | 9 cancers: BLCA; BRCA; COAD; LUAD; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.051; TCGA BRCA -0.06; TCGA COAD -0.08; TCGA LUAD -0.058; TCGA OV -0.089; TCGA SARC -0.107; TCGA THCA -0.071; TCGA STAD -0.05; TCGA UCEC -0.083 |
hsa-miR-146a-5p | RND2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.154; TCGA BRCA -0.206; TCGA CESC -0.306; TCGA COAD -0.461; TCGA ESCA -0.363; TCGA KIRC -0.218; TCGA LUAD -0.139; TCGA LUSC -0.321; TCGA OV -0.321; TCGA PAAD -0.392; TCGA SARC -0.241; TCGA THCA -0.286; TCGA STAD -0.502; TCGA UCEC -0.346 |
hsa-miR-146a-5p | C1orf21 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; OV; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.147; TCGA BRCA -0.267; TCGA ESCA -0.104; TCGA HNSC -0.103; TCGA KIRC -0.122; TCGA LIHC -0.12; TCGA OV -0.108; TCGA PRAD -0.098; TCGA SARC -0.169; TCGA STAD -0.234 |
hsa-miR-146a-5p | PAIP2B | 11 cancers: BLCA; ESCA; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.076; TCGA ESCA -0.292; TCGA KIRC -0.219; TCGA LUAD -0.16; TCGA OV -0.15; TCGA PAAD -0.298; TCGA PRAD -0.098; TCGA SARC -0.138; TCGA THCA -0.209; TCGA STAD -0.191; TCGA UCEC -0.24 |
hsa-miR-146a-5p | ARPP19 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.068; TCGA BRCA -0.094; TCGA CESC -0.075; TCGA ESCA -0.088; TCGA HNSC -0.056; TCGA KIRC -0.068; TCGA KIRP -0.078; TCGA LIHC -0.057; TCGA LUAD -0.152; TCGA LUSC -0.081; TCGA PAAD -0.06; TCGA SARC -0.099; TCGA STAD -0.118 |
hsa-miR-146a-5p | DSTYK | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.074; TCGA CESC -0.104; TCGA COAD -0.091; TCGA ESCA -0.115; TCGA HNSC -0.073; TCGA KIRC -0.143; TCGA KIRP -0.146; TCGA LUAD -0.107; TCGA LUSC -0.132; TCGA OV -0.057; TCGA PAAD -0.078; TCGA SARC -0.12; TCGA THCA -0.113; TCGA STAD -0.167; TCGA UCEC -0.115 |
hsa-miR-146a-5p | ABI2 | 12 cancers: BLCA; CESC; COAD; KIRC; KIRP; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.067; TCGA CESC -0.085; TCGA COAD -0.089; TCGA KIRC -0.109; TCGA KIRP -0.138; TCGA LUSC -0.086; TCGA OV -0.071; TCGA PAAD -0.097; TCGA SARC -0.158; TCGA THCA -0.098; TCGA STAD -0.209; TCGA UCEC -0.124 |
hsa-miR-146a-5p | FTO | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.077; TCGA BRCA -0.095; TCGA CESC -0.064; TCGA COAD -0.08; TCGA ESCA -0.124; TCGA HNSC -0.081; TCGA LIHC -0.067; TCGA LUSC -0.068; TCGA PAAD -0.087; TCGA SARC -0.072; TCGA THCA -0.064; TCGA STAD -0.189; TCGA UCEC -0.057 |
hsa-miR-146a-5p | ZCCHC14 | 11 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.089; TCGA COAD -0.079; TCGA ESCA -0.056; TCGA HNSC -0.08; TCGA LIHC -0.088; TCGA LUSC -0.106; TCGA OV -0.069; TCGA PAAD -0.052; TCGA SARC -0.098; TCGA STAD -0.103; TCGA UCEC -0.078 |
hsa-miR-146a-5p | SSBP2 | 11 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.104; TCGA BRCA -0.161; TCGA ESCA -0.265; TCGA KIRC -0.064; TCGA KIRP -0.093; TCGA LGG -0.154; TCGA OV -0.084; TCGA SARC -0.236; TCGA THCA -0.089; TCGA STAD -0.375; TCGA UCEC -0.172 |
hsa-miR-146a-5p | KCTD15 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.124; TCGA BRCA -0.093; TCGA COAD -0.253; TCGA ESCA -0.408; TCGA HNSC -0.11; TCGA KIRC -0.112; TCGA KIRP -0.427; TCGA LGG -0.223; TCGA LUSC -0.154; TCGA PAAD -0.089; TCGA SARC -0.352; TCGA THCA -0.254; TCGA STAD -0.399; TCGA UCEC -0.166 |
hsa-miR-146a-5p | KCNB1 | 9 cancers: BLCA; COAD; ESCA; LIHC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.311; TCGA COAD -0.781; TCGA ESCA -0.407; TCGA LIHC -0.523; TCGA PAAD -0.41; TCGA PRAD -0.135; TCGA SARC -0.513; TCGA STAD -1.109; TCGA UCEC -0.422 |
hsa-miR-146a-5p | UBR1 | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.057; TCGA BRCA -0.095; TCGA CESC -0.102; TCGA KIRC -0.096; TCGA KIRP -0.161; TCGA LUAD -0.071; TCGA LUSC -0.064; TCGA SARC -0.149; TCGA STAD -0.07 |
hsa-miR-146a-5p | NFASC | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.115; TCGA COAD -0.243; TCGA ESCA -0.397; TCGA HNSC -0.121; TCGA KIRP -0.289; TCGA PAAD -0.287; TCGA SARC -0.532; TCGA THCA -0.194; TCGA STAD -0.618; TCGA UCEC -0.23 |
hsa-miR-146a-5p | ZNF704 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.21; TCGA BRCA -0.088; TCGA CESC -0.265; TCGA COAD -0.213; TCGA KIRC -0.147; TCGA KIRP -0.367; TCGA LUAD -0.124; TCGA LUSC -0.208; TCGA SARC -0.415; TCGA THCA -0.139; TCGA STAD -0.324; TCGA UCEC -0.2 |
hsa-miR-146a-5p | MECP2 | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.064; TCGA BRCA -0.06; TCGA COAD -0.095; TCGA KIRC -0.087; TCGA KIRP -0.108; TCGA SARC -0.062; TCGA THCA -0.074; TCGA STAD -0.172; TCGA UCEC -0.087 |
hsa-miR-146a-5p | AR | 10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.321; TCGA BRCA -0.608; TCGA COAD -0.498; TCGA ESCA -0.305; TCGA LGG -0.48; TCGA LIHC -0.423; TCGA SARC -0.614; TCGA THCA -0.309; TCGA STAD -0.672; TCGA UCEC -0.298 |
hsa-miR-146a-5p | OTUD3 | 9 cancers: BLCA; KIRP; LGG; LUSC; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.13; TCGA KIRP -0.142; TCGA LGG -0.135; TCGA LUSC -0.082; TCGA OV -0.098; TCGA SARC -0.14; TCGA THCA -0.058; TCGA STAD -0.077; TCGA UCEC -0.114 |
hsa-miR-146a-5p | LONRF2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.424; TCGA BRCA -0.517; TCGA CESC -0.529; TCGA COAD -1.069; TCGA ESCA -0.367; TCGA KIRC -0.574; TCGA KIRP -0.491; TCGA PAAD -0.234; TCGA PRAD -0.109; TCGA SARC -0.935; TCGA THCA -0.255; TCGA STAD -0.756; TCGA UCEC -0.299 |
hsa-miR-146a-5p | PDE7B | 10 cancers: BLCA; CESC; COAD; KIRC; KIRP; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.229; TCGA CESC -0.237; TCGA COAD -0.285; TCGA KIRC -0.296; TCGA KIRP -0.295; TCGA OV -0.141; TCGA SARC -0.191; TCGA THCA -0.516; TCGA STAD -0.426; TCGA UCEC -0.271 |
hsa-miR-146a-5p | ZHX3 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.093; TCGA BRCA -0.126; TCGA CESC -0.067; TCGA ESCA -0.101; TCGA HNSC -0.166; TCGA KIRC -0.273; TCGA LGG -0.07; TCGA LIHC -0.198; TCGA LUSC -0.093; TCGA OV -0.066; TCGA PAAD -0.178; TCGA PRAD -0.054; TCGA SARC -0.07; TCGA THCA -0.138; TCGA STAD -0.268; TCGA UCEC -0.125 |
hsa-miR-146a-5p | CHD9 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.076; TCGA COAD -0.072; TCGA ESCA -0.089; TCGA HNSC -0.059; TCGA KIRC -0.064; TCGA KIRP -0.153; TCGA LIHC -0.092; TCGA LUSC -0.089; TCGA SARC -0.096; TCGA STAD -0.122; TCGA UCEC -0.083 |
hsa-miR-146a-5p | PACS2 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.085; TCGA BRCA -0.058; TCGA CESC -0.093; TCGA ESCA -0.066; TCGA HNSC -0.111; TCGA LUAD -0.063; TCGA LUSC -0.117; TCGA PAAD -0.076; TCGA STAD -0.087 |
hsa-miR-146a-5p | MXRA7 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.095; TCGA BRCA -0.069; TCGA CESC -0.209; TCGA COAD -0.3; TCGA ESCA -0.354; TCGA HNSC -0.204; TCGA KIRC -0.115; TCGA LUSC -0.134; TCGA OV -0.128; TCGA PAAD -0.18; TCGA SARC -0.096; TCGA THCA -0.094; TCGA STAD -0.471; TCGA UCEC -0.184 |
hsa-miR-146a-5p | ZNF793 | 11 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; OV; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.138; TCGA COAD -0.262; TCGA ESCA -0.206; TCGA KIRC -0.157; TCGA KIRP -0.202; TCGA LGG -0.121; TCGA OV -0.108; TCGA SARC -0.42; TCGA THCA -0.129; TCGA STAD -0.307; TCGA UCEC -0.07 |
hsa-miR-146a-5p | ZBTB10 | 11 cancers: BLCA; CESC; COAD; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.082; TCGA CESC -0.341; TCGA COAD -0.227; TCGA KIRC -0.129; TCGA KIRP -0.188; TCGA LGG -0.082; TCGA LUAD -0.148; TCGA PRAD -0.1; TCGA SARC -0.228; TCGA STAD -0.261; TCGA UCEC -0.148 |
hsa-miR-146a-5p | TAF9B | 9 cancers: BLCA; BRCA; COAD; KIRP; PAAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.082; TCGA BRCA -0.159; TCGA COAD -0.132; TCGA KIRP -0.101; TCGA PAAD -0.145; TCGA SARC -0.165; TCGA THCA -0.064; TCGA STAD -0.245; TCGA UCEC -0.094 |
hsa-miR-146a-5p | ZBTB16 | 10 cancers: BLCA; BRCA; COAD; KIRC; LIHC; PRAD; SARC; THCA; STAD; UCEC | RAID | TCGA BLCA -0.209; TCGA BRCA -0.266; TCGA COAD -0.59; TCGA KIRC -0.225; TCGA LIHC -0.288; TCGA PRAD -0.139; TCGA SARC -0.367; TCGA THCA -0.147; TCGA STAD -0.717; TCGA UCEC -0.222 |
hsa-miR-146a-5p | OLFML2A | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.188; TCGA COAD -0.255; TCGA ESCA -0.122; TCGA HNSC -0.138; TCGA KIRP -0.292; TCGA LUAD -0.1; TCGA LUSC -0.118; TCGA THCA -0.107; TCGA STAD -0.284; TCGA UCEC -0.207 |
hsa-miR-146a-5p | MMP16 | 9 cancers: BRCA; CESC; COAD; HNSC; KIRP; OV; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BRCA -0.202; TCGA CESC -0.323; TCGA COAD -0.511; TCGA HNSC -0.311; TCGA KIRP -0.182; TCGA OV -0.141; TCGA SARC -0.271; TCGA STAD -0.477; TCGA UCEC -0.241 |
hsa-miR-146a-5p | GOLM1 | 9 cancers: BRCA; CESC; KIRC; KIRP; LGG; LUAD; OV; PRAD; THCA | MirTarget | TCGA BRCA -0.127; TCGA CESC -0.152; TCGA KIRC -0.283; TCGA KIRP -0.139; TCGA LGG -0.131; TCGA LUAD -0.142; TCGA OV -0.053; TCGA PRAD -0.101; TCGA THCA -0.074 |
hsa-miR-146a-5p | TRIM37 | 10 cancers: BRCA; CESC; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BRCA -0.053; TCGA CESC -0.069; TCGA ESCA -0.077; TCGA LGG -0.063; TCGA LIHC -0.051; TCGA LUAD -0.152; TCGA LUSC -0.09; TCGA PAAD -0.088; TCGA SARC -0.095; TCGA STAD -0.063 |
hsa-miR-146a-5p | WWC2 | 9 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.112; TCGA CESC -0.2; TCGA COAD -0.242; TCGA HNSC -0.115; TCGA KIRC -0.245; TCGA KIRP -0.25; TCGA THCA -0.184; TCGA STAD -0.176; TCGA UCEC -0.17 |
hsa-miR-146a-5p | BCORL1 | 12 cancers: BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.078; TCGA CESC -0.145; TCGA COAD -0.148; TCGA HNSC -0.116; TCGA LGG -0.083; TCGA LUAD -0.108; TCGA LUSC -0.172; TCGA OV -0.064; TCGA SARC -0.105; TCGA THCA -0.088; TCGA STAD -0.112; TCGA UCEC -0.093 |
hsa-miR-146a-5p | VAT1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; STAD; UCEC | MirTarget | TCGA BRCA -0.079; TCGA CESC -0.144; TCGA COAD -0.109; TCGA ESCA -0.133; TCGA HNSC -0.172; TCGA LUSC -0.144; TCGA OV -0.059; TCGA STAD -0.155; TCGA UCEC -0.094 |
hsa-miR-146a-5p | MLLT1 | 10 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.066; TCGA ESCA -0.063; TCGA KIRC -0.057; TCGA KIRP -0.052; TCGA LIHC -0.069; TCGA OV -0.065; TCGA SARC -0.069; TCGA THCA -0.071; TCGA STAD -0.069; TCGA UCEC -0.065 |
hsa-miR-146a-5p | CXXC4 | 9 cancers: BRCA; COAD; LGG; LUAD; OV; PAAD; SARC; THCA; STAD | MirTarget | TCGA BRCA -0.177; TCGA COAD -0.2; TCGA LGG -0.163; TCGA LUAD -0.35; TCGA OV -0.28; TCGA PAAD -0.342; TCGA SARC -0.208; TCGA THCA -0.524; TCGA STAD -0.351 |
hsa-miR-146a-5p | USP47 | 10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.07; TCGA CESC -0.072; TCGA HNSC -0.078; TCGA KIRC -0.053; TCGA KIRP -0.104; TCGA OV -0.085; TCGA SARC -0.068; TCGA THCA -0.075; TCGA STAD -0.096; TCGA UCEC -0.065 |
hsa-miR-146a-5p | SYT1 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BRCA -0.386; TCGA CESC -0.273; TCGA COAD -0.31; TCGA HNSC -0.38; TCGA KIRC -0.535; TCGA KIRP -0.498; TCGA LUAD -0.27; TCGA LUSC -0.219; TCGA OV -0.183; TCGA STAD -0.584; TCGA UCEC -0.329 |
hsa-miR-146a-5p | IGFBP5 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; OV; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.196; TCGA CESC -0.268; TCGA COAD -0.525; TCGA ESCA -0.213; TCGA KIRC -0.366; TCGA KIRP -0.548; TCGA LUAD -0.165; TCGA OV -0.186; TCGA SARC -0.263; TCGA STAD -0.346; TCGA UCEC -0.414 |
hsa-miR-146a-5p | WNT3 | 9 cancers: BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; SARC | MirTarget | TCGA BRCA -0.202; TCGA ESCA -0.207; TCGA HNSC -0.243; TCGA LGG -0.207; TCGA LIHC -0.113; TCGA LUAD -0.18; TCGA LUSC -0.199; TCGA PRAD -0.081; TCGA SARC -0.236 |
hsa-miR-146a-5p | CDON | 9 cancers: BRCA; COAD; LGG; OV; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.197; TCGA COAD -0.285; TCGA LGG -0.154; TCGA OV -0.173; TCGA PAAD -0.172; TCGA SARC -0.245; TCGA THCA -0.337; TCGA STAD -0.567; TCGA UCEC -0.308 |
hsa-miR-146a-5p | RGP1 | 9 cancers: BRCA; CESC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BRCA -0.069; TCGA CESC -0.137; TCGA KIRC -0.156; TCGA KIRP -0.238; TCGA LUAD -0.087; TCGA LUSC -0.173; TCGA PAAD -0.137; TCGA SARC -0.182; TCGA UCEC -0.07 |
hsa-miR-146a-5p | USP22 | 10 cancers: BRCA; CESC; KIRC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | mirMAP | TCGA BRCA -0.09; TCGA CESC -0.07; TCGA KIRC -0.062; TCGA LUAD -0.104; TCGA LUSC -0.081; TCGA OV -0.084; TCGA PAAD -0.113; TCGA SARC -0.147; TCGA THCA -0.08; TCGA UCEC -0.052 |
hsa-miR-146a-5p | ADCY1 | 13 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.426; TCGA CESC -0.214; TCGA COAD -0.28; TCGA ESCA -0.187; TCGA KIRC -0.36; TCGA KIRP -0.668; TCGA OV -0.24; TCGA PAAD -0.387; TCGA PRAD -0.12; TCGA SARC -0.195; TCGA THCA -0.427; TCGA STAD -0.147; TCGA UCEC -0.193 |
hsa-miR-146a-5p | KIAA1958 | 13 cancers: BRCA; CESC; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA | mirMAP | TCGA BRCA -0.079; TCGA CESC -0.108; TCGA COAD -0.082; TCGA KIRC -0.132; TCGA KIRP -0.266; TCGA LGG -0.131; TCGA LIHC -0.081; TCGA LUAD -0.167; TCGA LUSC -0.21; TCGA OV -0.081; TCGA PAAD -0.234; TCGA SARC -0.29; TCGA THCA -0.121 |
hsa-miR-146a-5p | PRTG | 10 cancers: BRCA; CESC; COAD; KIRC; KIRP; LGG; OV; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.267; TCGA CESC -0.357; TCGA COAD -0.598; TCGA KIRC -0.587; TCGA KIRP -0.416; TCGA LGG -0.277; TCGA OV -0.227; TCGA THCA -0.321; TCGA STAD -0.403; TCGA UCEC -0.318 |
hsa-miR-146a-5p | TBC1D16 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA; STAD | mirMAP | TCGA BRCA -0.102; TCGA CESC -0.121; TCGA COAD -0.105; TCGA HNSC -0.176; TCGA KIRC -0.331; TCGA KIRP -0.184; TCGA LIHC -0.147; TCGA LUAD -0.08; TCGA LUSC -0.103; TCGA OV -0.097; TCGA THCA -0.055; TCGA STAD -0.061 |
hsa-miR-146a-5p | SGCD | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.205; TCGA CESC -0.268; TCGA COAD -0.72; TCGA ESCA -0.397; TCGA HNSC -0.3; TCGA LGG -0.1; TCGA PRAD -0.197; TCGA SARC -0.228; TCGA STAD -0.538; TCGA UCEC -0.467 |
hsa-miR-146a-5p | TANC2 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.213; TCGA CESC -0.096; TCGA ESCA -0.189; TCGA HNSC -0.104; TCGA KIRC -0.147; TCGA KIRP -0.171; TCGA LGG -0.067; TCGA LUSC -0.155; TCGA PAAD -0.102; TCGA STAD -0.173; TCGA UCEC -0.237 |
hsa-miR-146a-5p | CUEDC1 | 9 cancers: BRCA; CESC; ESCA; KIRC; LGG; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BRCA -0.161; TCGA CESC -0.136; TCGA ESCA -0.105; TCGA KIRC -0.126; TCGA LGG -0.082; TCGA LUSC -0.067; TCGA PAAD -0.121; TCGA SARC -0.067; TCGA STAD -0.203 |
hsa-miR-146a-5p | TMEM136 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.104; TCGA CESC -0.223; TCGA COAD -0.103; TCGA ESCA -0.186; TCGA HNSC -0.089; TCGA KIRC -0.108; TCGA KIRP -0.096; TCGA LUSC -0.134; TCGA PRAD -0.099; TCGA SARC -0.157; TCGA THCA -0.05; TCGA STAD -0.29; TCGA UCEC -0.172 |
hsa-miR-146a-5p | CYB5D1 | 10 cancers: BRCA; CESC; ESCA; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.166; TCGA CESC -0.065; TCGA ESCA -0.077; TCGA LIHC -0.05; TCGA LUSC -0.1; TCGA PAAD -0.223; TCGA PRAD -0.081; TCGA SARC -0.102; TCGA THCA -0.21; TCGA STAD -0.085 |
hsa-miR-146a-5p | SHISA6 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.292; TCGA COAD -0.398; TCGA ESCA -0.293; TCGA HNSC -0.255; TCGA KIRC -0.454; TCGA KIRP -0.421; TCGA PRAD -0.135; TCGA THCA -0.408; TCGA STAD -0.191 |
hsa-miR-146a-5p | OSBPL1A | 10 cancers: CESC; ESCA; HNSC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA CESC -0.127; TCGA ESCA -0.13; TCGA HNSC -0.113; TCGA LUAD -0.144; TCGA LUSC -0.126; TCGA OV -0.072; TCGA SARC -0.111; TCGA THCA -0.122; TCGA STAD -0.317; TCGA UCEC -0.208 |
hsa-miR-146a-5p | FAM168B | 12 cancers: CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.076; TCGA COAD -0.051; TCGA KIRC -0.12; TCGA KIRP -0.086; TCGA LIHC -0.052; TCGA LUAD -0.102; TCGA LUSC -0.12; TCGA OV -0.096; TCGA SARC -0.158; TCGA THCA -0.083; TCGA STAD -0.175; TCGA UCEC -0.111 |
hsa-miR-146a-5p | ZNF275 | 10 cancers: CESC; COAD; KIRC; KIRP; LGG; LIHC; OV; SARC; THCA; UCEC | MirTarget | TCGA CESC -0.123; TCGA COAD -0.12; TCGA KIRC -0.08; TCGA KIRP -0.177; TCGA LGG -0.1; TCGA LIHC -0.066; TCGA OV -0.059; TCGA SARC -0.054; TCGA THCA -0.146; TCGA UCEC -0.094 |
hsa-miR-146a-5p | ESYT2 | 11 cancers: CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.074; TCGA COAD -0.056; TCGA ESCA -0.113; TCGA HNSC -0.076; TCGA KIRP -0.06; TCGA LIHC -0.07; TCGA LUAD -0.068; TCGA LUSC -0.105; TCGA SARC -0.151; TCGA STAD -0.155; TCGA UCEC -0.069 |
hsa-miR-146a-5p | ZNF532 | 11 cancers: CESC; COAD; ESCA; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.098; TCGA COAD -0.293; TCGA ESCA -0.177; TCGA KIRP -0.15; TCGA LGG -0.062; TCGA LUAD -0.061; TCGA LUSC -0.069; TCGA PRAD -0.112; TCGA SARC -0.182; TCGA STAD -0.236; TCGA UCEC -0.154 |
hsa-miR-146a-5p | ZNF649 | 10 cancers: CESC; COAD; KIRC; KIRP; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.146; TCGA COAD -0.251; TCGA KIRC -0.215; TCGA KIRP -0.232; TCGA OV -0.147; TCGA PRAD -0.143; TCGA SARC -0.087; TCGA THCA -0.077; TCGA STAD -0.184; TCGA UCEC -0.077 |
hsa-miR-146a-5p | YLPM1 | 9 cancers: CESC; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; SARC; UCEC | MirTarget | TCGA CESC -0.053; TCGA ESCA -0.056; TCGA KIRC -0.113; TCGA KIRP -0.165; TCGA LGG -0.077; TCGA LUSC -0.097; TCGA PAAD -0.053; TCGA SARC -0.053; TCGA UCEC -0.071 |
hsa-miR-146a-5p | EXOC5 | 11 cancers: CESC; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.1; TCGA ESCA -0.152; TCGA HNSC -0.103; TCGA KIRP -0.093; TCGA LUAD -0.051; TCGA LUSC -0.094; TCGA OV -0.051; TCGA PAAD -0.093; TCGA SARC -0.065; TCGA STAD -0.091; TCGA UCEC -0.069 |
hsa-miR-146a-5p | HS1BP3 | 9 cancers: CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA CESC -0.076; TCGA ESCA -0.054; TCGA HNSC -0.1; TCGA LIHC -0.12; TCGA LUAD -0.099; TCGA LUSC -0.061; TCGA PRAD -0.07; TCGA SARC -0.077; TCGA STAD -0.123 |
hsa-miR-146a-5p | RAB3B | 10 cancers: CESC; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | mirMAP | TCGA CESC -0.324; TCGA HNSC -0.331; TCGA KIRC -0.391; TCGA LUAD -0.281; TCGA LUSC -0.465; TCGA OV -0.165; TCGA PAAD -0.283; TCGA PRAD -0.235; TCGA SARC -0.208; TCGA STAD -0.191 |
hsa-miR-146a-5p | HIC2 | 10 cancers: CESC; HNSC; KIRP; LGG; LUAD; LUSC; OV; SARC; THCA; UCEC | mirMAP | TCGA CESC -0.114; TCGA HNSC -0.089; TCGA KIRP -0.084; TCGA LGG -0.136; TCGA LUAD -0.122; TCGA LUSC -0.149; TCGA OV -0.105; TCGA SARC -0.072; TCGA THCA -0.12; TCGA UCEC -0.064 |
hsa-miR-146a-5p | PYGO1 | 12 cancers: CESC; ESCA; KIRC; KIRP; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.291; TCGA ESCA -0.291; TCGA KIRC -0.391; TCGA KIRP -0.578; TCGA LGG -0.127; TCGA LUSC -0.27; TCGA OV -0.218; TCGA PRAD -0.128; TCGA SARC -0.223; TCGA THCA -0.137; TCGA STAD -0.559; TCGA UCEC -0.356 |
hsa-miR-146a-5p | SMAD2 | 9 cancers: CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD | mirMAP | TCGA CESC -0.067; TCGA ESCA -0.08; TCGA KIRC -0.094; TCGA KIRP -0.092; TCGA LUAD -0.094; TCGA LUSC -0.052; TCGA PAAD -0.053; TCGA SARC -0.078; TCGA STAD -0.07 |
hsa-miR-146a-5p | MAN1A2 | 9 cancers: CESC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; STAD | mirMAP | TCGA CESC -0.083; TCGA KIRC -0.104; TCGA KIRP -0.239; TCGA LIHC -0.076; TCGA LUAD -0.114; TCGA LUSC -0.091; TCGA SARC -0.133; TCGA THCA -0.076; TCGA STAD -0.052 |
hsa-miR-146a-5p | VGLL3 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; STAD; UCEC | mirMAP | TCGA CESC -0.387; TCGA COAD -0.547; TCGA ESCA -0.23; TCGA HNSC -0.152; TCGA KIRC -0.221; TCGA KIRP -0.433; TCGA PRAD -0.27; TCGA STAD -0.349; TCGA UCEC -0.271 |
hsa-miR-146a-5p | TM9SF2 | 9 cancers: CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD | miRNATAP | TCGA CESC -0.091; TCGA COAD -0.085; TCGA KIRC -0.112; TCGA KIRP -0.093; TCGA LIHC -0.055; TCGA LUAD -0.097; TCGA LUSC -0.09; TCGA OV -0.088; TCGA PAAD -0.111 |
hsa-miR-146a-5p | PLEKHM3 | 12 cancers: COAD; ESCA; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.097; TCGA ESCA -0.084; TCGA KIRP -0.076; TCGA LIHC -0.059; TCGA LUAD -0.082; TCGA LUSC -0.094; TCGA OV -0.068; TCGA PAAD -0.086; TCGA SARC -0.135; TCGA THCA -0.088; TCGA STAD -0.246; TCGA UCEC -0.145 |
hsa-miR-146a-5p | ZNF813 | 9 cancers: COAD; KIRC; KIRP; LGG; LUAD; OV; PRAD; SARC; UCEC | MirTarget | TCGA COAD -0.419; TCGA KIRC -0.105; TCGA KIRP -0.223; TCGA LGG -0.126; TCGA LUAD -0.093; TCGA OV -0.07; TCGA PRAD -0.162; TCGA SARC -0.136; TCGA UCEC -0.073 |
hsa-miR-146a-5p | NOS1 | 9 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; STAD; UCEC | mirMAP | TCGA COAD -0.847; TCGA ESCA -0.824; TCGA HNSC -0.351; TCGA KIRC -0.323; TCGA KIRP -0.504; TCGA LUSC -0.386; TCGA OV -0.266; TCGA STAD -0.822; TCGA UCEC -0.17 |
hsa-miR-146a-5p | FOXP2 | 9 cancers: COAD; ESCA; KIRC; LGG; LUAD; PAAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.842; TCGA ESCA -0.8; TCGA KIRC -0.266; TCGA LGG -0.469; TCGA LUAD -0.144; TCGA PAAD -0.308; TCGA SARC -0.216; TCGA THCA -0.537; TCGA STAD -0.906 |
hsa-miR-146a-5p | PLEKHG4B | 11 cancers: ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; SARC; STAD; UCEC | mirMAP | TCGA ESCA -0.431; TCGA HNSC -0.199; TCGA KIRC -0.759; TCGA KIRP -0.44; TCGA LGG -0.182; TCGA LUAD -0.201; TCGA LUSC -0.303; TCGA OV -0.213; TCGA SARC -0.204; TCGA STAD -0.324; TCGA UCEC -0.144 |
hsa-miR-146a-5p | CSRNP3 | 9 cancers: HNSC; KIRC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC | mirMAP | TCGA HNSC -0.191; TCGA KIRC -0.338; TCGA KIRP -0.262; TCGA LUAD -0.348; TCGA LUSC -0.143; TCGA OV -0.203; TCGA SARC -0.218; TCGA STAD -0.402; TCGA UCEC -0.177 |
Enriched cancer pathways of putative targets